World is a TAXing Place..
Taxation is perhaps the single biggest expense for any individual. It is a forced expense by the system of every nation. Therefore, if you are looking forward to moving to…
Wealth is useless if health is gone !
At Wealthstrategies.in, I am supposed to be writing about how to grow your money. But let me give you a spoiler. I think your money is worthless if you cannot…
US Bond Volatility becomes Scary
Just after a day when President Trump dashed the hopes for continuing QE till election, the Equity and Bond markets saw volatility. The Bond Volatility index in particular went through…
India’s recovery : Real or Illusion ?
Economists are skeptical amongst signs of recovery. GST collections are symbolic of economic activities within the economy. Since September’20 GST collections have been highest in last 7 months, and also…
SEBI bans AT1 Bonds for Retail Investors
The scars from Yes Bank AT1 Bonds write-off are still fresh in the minds of investors. AT1 Bonds are inherently risky (often riskier than Equities), yet they are sold like…
Stock Market Overvalued or Not ? CAPE SHILLER Values
BSE SENSEX CAPE SHILLER VALUATION Professor Robert Shiller of Yale University developed the Shiller PE 10 to more accurately reflect long term trends and smooth volatile components of the standard…
GILTS are Out, Floater are In
Last 30 days saw GILT funds lose their AUM. Credit Risk funds also continued their AUM losing streak. But a big surprise happened in the form of Floating Rate category.…
Looking beyond the Obvious: GOLD & SILVER
E.B. Tucker forecasts $40 silver price, $2,500 gold by year-end Key take aways: 1. US Fed is printing money to the tune of 5 Trillion USD over 2020 and 2021.…
OUR CHAT WITH GEORGE JOSEPH, CEO & CIO – ITI MUTUAL FUND
The ongoing disconnect between Dalal Street & Main Street is making everyone scratch their heads. The rise and rise of Sensex is gravity defying. To understand the risk reward matrix…
Invest in Pharma Sector for next 5-6 years
Pharma sector is an OUTPERFORM call for next 5-6 years A health crises like COVID19 has brought the focus back on pharma & healthcare. The sector was recovering well during…